Rapport Therapeutics, Inc. Common Stock (RAPP) Earnings
Rapport Therapeutics, Inc. Common Stock is expected to report next earnings on November 5, 2026 (in NaN days), with a consensus EPS estimate of $-1.21. RAPP has beaten EPS estimates in 6 of its last 9 reported quarters (average surprise +4.0% over the last four).
Next earnings
Nov 5, 2026in NaN days
EPS est $-1.21 · Revenue est —
Track record
Beat EPS in 6 of 9 quarters
Avg surprise +4.0% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 5, 2026 | $-1.12 | $-1.19 | -6.2% | — | — |
| May 7, 2026 | $-0.56 | $-0.42 | +25.0% | $20M | +166.7% |
| Mar 10, 2026 | $-0.65 | $-0.72 | -10.6% | — | — |
| Nov 6, 2025 | $-0.77 | $-0.71 | +7.8% | — | — |
| Aug 7, 2025 | $-0.87 | $-0.75 | +13.8% | — | — |
| May 8, 2025 | $-0.77 | $-0.68 | +11.7% | — | — |
| Mar 11, 2025 | $-0.62 | $-0.57 | +8.1% | — | — |
| Nov 7, 2024 | $-0.57 | $-0.50 | +12.3% | — | — |
| Aug 8, 2024 | $-0.68 | $-1.70 | -150.0% | — | — |
| Mar 30, 2024 | — | $-0.12 | — | — | — |
| Sep 30, 2023 | — | $-0.05 | — | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.